Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association - PubMed
- ️Fri Jan 01 2016
Review
Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association
Robert L Page 2nd et al. Circulation. 2016.
Erratum in
-
[No authors listed] [No authors listed] Circulation. 2016 Sep 20;134(12):e261. doi: 10.1161/CIR.0000000000000449. Circulation. 2016. PMID: 27647303 No abstract available.
Abstract
Heart failure is a common, costly, and debilitating syndrome that is associated with a highly complex drug regimen, a large number of comorbidities, and a large and often disparate number of healthcare providers. All of these factors conspire to increase the risk of heart failure exacerbation by direct myocardial toxicity, drug-drug interactions, or both. This scientific statement is designed to serve as a comprehensive and accessible source of drugs that may cause or exacerbate heart failure to assist healthcare providers in improving the quality of care for these patients.
Keywords: AHA Scientific Statements; drug interactions; drug monitoring; drug therapy; drug-related adverse effects and adverse reactions; heart failure; nonprescription drugs.
© 2016 American Heart Association, Inc.
Similar articles
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. Yancy CW, et al. Circulation. 2013 Oct 15;128(16):1810-52. doi: 10.1161/CIR.0b013e31829e8807. Epub 2013 Jun 5. Circulation. 2013. PMID: 23741057 No abstract available.
-
Stout KK, Broberg CS, Book WM, Cecchin F, Chen JM, Dimopoulos K, Everitt MD, Gatzoulis M, Harris L, Hsu DT, Kuvin JT, Law Y, Martin CM, Murphy AM, Ross HJ, Singh G, Spray TL; American Heart Association Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology, and Council on Cardiovascular Radiology and Imaging. Stout KK, et al. Circulation. 2016 Feb 23;133(8):770-801. doi: 10.1161/CIR.0000000000000352. Epub 2016 Jan 19. Circulation. 2016. PMID: 26787728 Review. No abstract available.
-
Weintraub NL, Collins SP, Pang PS, Levy PD, Anderson AS, Arslanian-Engoren C, Gibler WB, McCord JK, Parshall MB, Francis GS, Gheorghiade M; American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Weintraub NL, et al. Circulation. 2010 Nov 9;122(19):1975-96. doi: 10.1161/CIR.0b013e3181f9a223. Epub 2010 Oct 11. Circulation. 2010. PMID: 20937981 No abstract available.
-
Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, McCoy RG, Mentz RJ, Piña IL; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America. Dunlay SM, et al. Circulation. 2019 Aug 13;140(7):e294-e324. doi: 10.1161/CIR.0000000000000691. Epub 2019 Jun 6. Circulation. 2019. PMID: 31167558 Review.
-
Jurgens CY, Goodlin S, Dolansky M, Ahmed A, Fonarow GC, Boxer R, Arena R, Blank L, Buck HG, Cranmer K, Fleg JL, Lampert RJ, Lennie TA, Lindenfeld J, Piña IL, Semla TP, Trebbien P, Rich MW; American Heart Association Council on Quality of Care and Outcomes Research; Heart Failure Society of America. Jurgens CY, et al. J Card Fail. 2015 Apr;21(4):263-99. doi: 10.1016/j.cardfail.2015.02.007. J Card Fail. 2015. PMID: 25863664 Review. No abstract available.
Cited by
-
Cardioprotective effects of Moku-boi-to and its impact on AngII-induced cardiomyocyte hypertrophy.
Tagashira H, Abe F, Sato-Numata K, Aizawa K, Hirasawa K, Kure Y, Iwata D, Numata T. Tagashira H, et al. Front Cell Dev Biol. 2023 Nov 7;11:1264076. doi: 10.3389/fcell.2023.1264076. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38020917 Free PMC article.
-
Lee SB, D'Andrea E, Desai RJ. Lee SB, et al. J Am Heart Assoc. 2023 Jul 18;12(14):e029589. doi: 10.1161/JAHA.123.029589. Epub 2023 Jul 14. J Am Heart Assoc. 2023. PMID: 37449570 Free PMC article. No abstract available.
-
Lassalle M, Colas S, Rudnichi A, Zureik M, Dray-Spira R. Lassalle M, et al. Clin Orthop Relat Res. 2018 Jul;476(7):1441-1451. doi: 10.1097/01.blo.0000533617.64678.69. Clin Orthop Relat Res. 2018. PMID: 29698302 Free PMC article.
-
Piperacillin/Tazobactam Use vs Cefepime May Be Associated With Acute Decompensated Heart Failure.
Scheerenberger HR, Kullab S, Elgazzar A, Lewis N, Shams WE. Scheerenberger HR, et al. Fed Pract. 2024 Feb;41(2):44-47. doi: 10.12788/fp.0451. Epub 2024 Feb 12. Fed Pract. 2024. PMID: 38835923 Free PMC article.
-
ST2 as a Biomarker to Show the Preventive Effect of Exercise in Myocardial Injury by Doxorubicin?
Lee J, Kim EJ. Lee J, et al. Int J Heart Fail. 2021 Mar 30;3(2):117-120. doi: 10.36628/ijhf.2021.0003. eCollection 2021 Apr. Int J Heart Fail. 2021. PMID: 36262878 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical